Quantbot Technologies LP Cytosorbents Corp Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $17,010 - $34,062	-4,200 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$7.0 - $9.71 $25,200 - $34,956	3,600 Added 600.0%	4,200 $34,000
Q2 2021 Aug 12, 2021	BUY	$7.55 - $9.42 $4,530 - $5,652	600 New	600 $4,000
Q3 2020 Nov 16, 2020	SELL	$7.37 - $11.54 $8,984 - $14,067	-1,219 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $7,655 - $12,909	1,219 New	1,219 $12,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.